Image

Rakesh K. Bagai, MD

Medical Oncologist

Director of Skin & Sarcoma

Gastrointestinal Malignancies

"Dr. Bagai has a good personal touch with his patients."

Dr. Rakesh Bagai joined Ironwood Cancer & Research Centers in July 2014. He attended medical school at University of Cincinnati College of Medicine and completed his Internal Medicine residency at University Hospitals Case Medical Center. Following residency, Dr. Bagai went on to complete a Hematology/Oncology fellowship at the renowned Cleveland Clinic, where he received the prestigious Caregiver Appreciation Award in recognition of outstanding leadership and exemplary oncology care.

Dr. Bagai specializes in gastrointestinal, CNS and skin & sarcoma malignancies. He has actively been involved in clinical research trials to further understand factors in cancer resistance and to develop novel treatment strategies. He has published in several well recognized, peer-reviewed journals and has presented at national meetings. He is at present an investigator in research trials .He has been selected by his professional peers as a Top Doc in PHOENIX Magazine. He is a member of the American Society of Clinical Oncology and the American Society of Hematology. He is married with two sons and in his spare time enjoys basketball and tennis.

Present Title & Subspecialties

Title

Director of Skin & Sarcoma

Subspecialties

Director of Skin & SarcomaGastrointestinal Malignancies

Education & Training

Medical School

University of Cincinnati College of Medicine

Fellowships

Cleveland Clinic, Cleveland, OH, Hematology & Medical Oncology
Cancers Treated
Certifications & Professional Memberships

  • Board Certified in Hematology & Medical Oncology
  • Board Certified in Internal Medicine
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Medical Association
  • Indian Student Association

Publications

Bagai R, Zhang W, Leahy P, Yin L, Ma P.  CARD8/BCL-2 Cascade in Early Adaptive Drug Resistant Tumor Escape Against Targeted Inhibitors in NSCLC.  J Clin Oncol 31, 2013 (suppl; abstr e22032).  2013 American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, IL, June 2013.

 

Yin L, Shi I, Zhang W, Bagai R, Feng Y, Ma P.  Studies of Early Adaptive Resistance in Mutant-EGFR and EML4-ALK Addicted Non-Small Cell Lung Cancer in Escape Against Small Molecule Inhibitors.  American Association for Cancer Research (AACR) Annual Meeting.  Washington, DC, April, 2013.

 

Bagai R, Pennell N.  ZEPHYR Illustrates the Perils of Testing Targeted Treatments in Unselected Non-Small-Cell Lung Cancer Patients.  Translational Lung Cancer Research.  2013 February, 2 (1): E1-E3.

 

Bagai R, Ma P. The Role of the Insulin-like Growth Factor-1 Receptor (IGF-1R), Phosphatase and Tensin Homolog (PTEN), c-Met, and the PI3-Kinase Pathway in Colorectal Cancer.  Current Colorectal Cancer Reports. 2012 December; 8(4): 243-253.

 

Bagai R, Ma P. Tasisulam, an Acyl Sulfonamide Cell Cycle Inhibitor for the Treatment of Solid and Liquid Tumors.  IDrugs.  November 2012.

 

Bagai R, Ma P. Combined Treatment with MET Inhibitors and Other Therapies in Lung Cancer.  Translational Lung Cancer Research. 2012 September; 1(3): 214-218.

 

Prithviraj GK, Koroukian S, Margevicius S, Berger NA, Bagai R, Owusu C.  Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.  J Geriatr Oncol. 2012 Jul 1;3(3):228-237.  PMID: 22712030

 

Fan W, Tang Z, Yin L, Morrison B, Hafez-Khayyata S, Fu P, Huang H, Bagai R, Jiang S, Kresak A, Howell S, Vasanji A, Flask CA, Halmos B, Koon H, Ma PC.  MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents.  Cancer Res. 2011 Jul 1;71(13):4494-505.  PMID: 21555370

 

Bagai R, Fan W, Ma P.  ARQ-197, an Oral Small-Molecule Inhibitor of c-Met for the Treatment of Solid Tumors. IDrugs. 2010 Jun;13(6):404-14.  PMID: 20506063

 

Bagai R, Valujskikh A, Canaday DH, Bailey E, Lalli PN, Harding CV, Heeger PS. Mouse Endothelial Cells Cross-Present Lymphocyte-Derived Antigen on Class I MHC via a TAP1- and Proteasome-Dependent Pathway.  J Immunol. 2005 Jun 15;174(12):7711-5. PMID: 15944272

Honors & Awards

PHOENIX Magazine Top Doctor Award 2023

Caregiver Appreciation Award – Cleveland Clinic Recognition of Leadership and Exemplary Oncology Care, 2013

Carpenter Award – University Hospitals Case Medical Center Recognition of Clinical Excellence, 2011

Young Investigator Award – American Transplant Congress Recognition of Research Excellence, 2005

John Carroll University President’s Honor Award, 2000-2003

John Huntington Scholarship, 2000-2003

American Values Scholarship, 2000-2003

Minority Affairs Honor Award, 2000-2003

Corporate Intern Scholarship, 2000-2003

CV
Videos

Videos

Languages

Location

Scottsdale

8880 E. Desert Cove Ave.

Scottsdale, AZ 85260

Hours:

Monday-Friday

8am-5pm

Contact
(480) 314-6670
480-257-1997
Scottsdale (Osborn)

3501 N. Scottsdale Rd. Suite 347
Scottsdale, AZ 85251

Hours:

Monday – Friday

8am-5pm

Contact
480-314-6670
480-257-1997
Reviews for Rakesh K. Bagai, MD
  • Rakesh Testimonial
  • Rakesh Bagai Testimonial
  • Image
  • Image
  • Image
  • Image
    pixel